What does this research mean for the field?

Distinct plasma signatures predict region-specific Alzheimer's pathology and cognitive decline. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

The research aims to identify how plasma biomarkers can indicate Alzheimer's disease (AD) pathways and cognitive decline.

March 16, 2026Open Access

Multivariate patterns of plasma biomarkers predict region‐specific Alzheimer's pathology and cognitive decline across independent cohorts

Key Points

The research aims to identify how plasma biomarkers can indicate Alzheimer's disease (AD) pathways and cognitive decline.
Analyzed plasma samples from multiple cohorts
Identified distinct biomarker signatures
Used statistical models to correlate biological patterns with cognitive outcomes
Distinct plasma signatures correlate with AD pathology
Blood-based biomarkers can predict cognitive decline
Findings support cost-effective screening for early AD detection

Abstract

Distinct plasma signatures reflect underlying AD pathways, supporting the use of blood-based biomarkers as cost-effective, noninvasive tools for early detection, disease monitoring, and individualized risk profiling.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Zamani et al. (Sun,) studied this question.

synapsesocial.com/papers/69b79e6e8166e15b153abc3e https://doi.org/https://doi.org/10.1002/alz.71265

Bookmark

View Full Paper